• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名青春期前患者高级别非肌层浸润性尿路上皮癌的经尿道膀胱肿瘤电切术及膀胱内卡介苗治疗管理

Management of High-grade, Nonmuscle Invasive Urothelial Carcinoma in a Prepubertal Patient With TURBT and Intravesical BCG.

作者信息

Rague James T, Lee Richard S

机构信息

Boston Medical Center, Department of Urology, Boston MA.

Harvard Medical School, Department of Surgery and Boston Children's Hospital, Department of Urology, Boston, MA.

出版信息

Urology. 2019 Feb;124:257-259. doi: 10.1016/j.urology.2018.10.028. Epub 2018 Oct 24.

DOI:10.1016/j.urology.2018.10.028
PMID:30366046
Abstract

High-grade urothelial carcinoma of the bladder is rare in the pediatric population with no established guidelines for management. We treated a single female patient, 10 years of age, who was found to have high-grade, nonmuscle invasive urothelial carcinoma endoscopically and with intravesical bacille calmette guerin (BCG). Given the child's age, no local adult institution could provide BCG therapy. Utilizing the experience of the local adult institutions, we developed a comprehensive protocol for first-time delivery of BCG at a free-standing children's hospital. The patient has undergone successful induction and maintenance BCG for 7 cycles without disease recurrence and minimal side effects.

摘要

高级别膀胱尿路上皮癌在儿童群体中较为罕见,目前尚无既定的管理指南。我们治疗了一名10岁的女性患者,经内镜检查发现其患有高级别非肌层浸润性膀胱尿路上皮癌,并接受了膀胱内卡介苗(BCG)治疗。鉴于患儿的年龄,当地没有成人机构能够提供卡介苗治疗。我们借鉴当地成人机构的经验,制定了一套在一家独立儿童医院首次使用卡介苗的综合方案。该患者已成功接受了7个周期的卡介苗诱导和维持治疗,无疾病复发,且副作用极小。

相似文献

1
Management of High-grade, Nonmuscle Invasive Urothelial Carcinoma in a Prepubertal Patient With TURBT and Intravesical BCG.一名青春期前患者高级别非肌层浸润性尿路上皮癌的经尿道膀胱肿瘤电切术及膀胱内卡介苗治疗管理
Urology. 2019 Feb;124:257-259. doi: 10.1016/j.urology.2018.10.028. Epub 2018 Oct 24.
2
Retrospective study of various conservative treatment options with bacille Calmette-Guérin in bladder urothelial carcinoma T1G3: Maintenance therapy.卡介苗对膀胱尿路上皮癌T1G3的多种保守治疗方案的回顾性研究:维持治疗。
Actas Urol Esp. 2016 Jul-Aug;40(6):370-7. doi: 10.1016/j.acuro.2015.12.009. Epub 2016 Feb 24.
3
Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non-muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy.膀胱内注射纳米白蛋白结合紫杉醇治疗既往卡介苗治疗后复发的非肌层浸润性膀胱癌的长期生存结果
Urology. 2017 May;103:149-153. doi: 10.1016/j.urology.2017.01.018. Epub 2017 Feb 2.
4
Recurrent Bladder Cancer in a Teenage Male.青少年男性复发性膀胱癌。
Urology. 2020 Jul;141:135-138. doi: 10.1016/j.urology.2020.04.031. Epub 2020 Apr 22.
5
Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette-Guérin immunotherapy?对于接受卡介苗膀胱内免疫治疗的原发性膀胱T1G3尿路上皮癌患者,是否有可能停止随访?
World J Urol. 2017 Feb;35(2):237-243. doi: 10.1007/s00345-016-1856-9. Epub 2016 Jun 9.
6
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.对于新诊断的非肌层浸润性膀胱癌,单次广泛经尿道切除术后联合适当的膀胱内灌注治疗的肿瘤学结局。
Int Urol Nephrol. 2015 Sep;47(9):1509-14. doi: 10.1007/s11255-015-1048-3. Epub 2015 Jul 7.
7
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients.膀胱内卡介苗联合癌症疫苗可增强非肌层浸润性膀胱癌患者的局部 T 细胞应答。
Clin Cancer Res. 2017 Feb 1;23(3):717-725. doi: 10.1158/1078-0432.CCR-16-1189. Epub 2016 Aug 12.
8
Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer.BCG 诱导治疗非肌层浸润性膀胱癌 21 例患者的前列腺尿道复发发生率及处理。
Urol Oncol. 2024 Sep;42(9):290.e11-290.e16. doi: 10.1016/j.urolonc.2024.04.017. Epub 2024 Apr 29.
9
Patient Compliance With Maintenance Intravesical Therapy for Nonmuscle Invasive Bladder Cancer.非肌层浸润性膀胱癌患者维持膀胱灌注治疗的依从性
Urology. 2018 Aug;118:107-113. doi: 10.1016/j.urology.2018.04.039. Epub 2018 May 21.
10
Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.膀胱内卡介苗治疗T1期3级膀胱移行细胞癌:57例患者的复发、进展及生存情况研究
J Urol. 2003 Jun;169(6):2110-2. doi: 10.1097/01.ju.0000066840.42991.4a.

引用本文的文献

1
Synergistic intravesical instillation for bladder cancer: CRISPR-Cas13a and fenbendazole combination therapy.协同腔内灌注治疗膀胱癌:CRISPR-Cas13a 和芬苯达唑联合治疗。
J Exp Clin Cancer Res. 2024 Aug 12;43(1):223. doi: 10.1186/s13046-024-03146-0.